Cue Biopharma Inc. (NASDAQ: CUE) Stock Information | RedChip

Cue Biopharma Inc. (NASDAQ: CUE) Listen to this Section


$0.67
+0.0741 ( +12.48% ) 192.4K

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

Market Data


Open


$0.67

Previous close


$0.59

Volume


192.4K

Market cap


$33.03M

Day range


$0.59 - $0.68

52 week range


$0.58 - $3.25

Insider Ownership Transactions

Total Amount Purchased: -1,828,800.00 | $ -1,221,638.40

Date Type Amount Purchased Purchaser
2024-06-07 Sale -60000.00 Millar Kerri-Ann
2024-06-07 Sale -60000.00 Sandercock Colin
2024-06-07 Sale -125000.00 Levisetti Matteo
2024-06-07 Sale -48800.00 Fox Michael J
2024-06-07 Sale -150000.00 Suri Anish
2024-03-08 Sale -250000.00 Millar Kerri-Ann
2024-03-08 Sale -300000.00 Suri Anish
2024-03-08 Sale -400000.00 PASSERI DANIEL R
2024-03-08 Sale -260000.00 Levisetti Matteo
2024-03-08 Sale -175000.00 Sandercock Colin

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 77 Aug 14, 2024
8-k 8K-related 13 Jul 25, 2024
3 Insider transactions 2 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
8-k 8K-related 11 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
10-q Quarterly Reports 72 May 09, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.